Pacer Advisors, Inc. Exact Sciences Corp Transaction History

Pacer Advisors, Inc.

  • $41.8 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $74,765 - $134,336
1,809 Added 255.51%
2,517 $106,000
Q1 2024

May 10, 2024
BUY
$56.27 - $73.77 $39,839 - $52,229
708 New
708 $48,000
Q1 2022

Apr 05, 2022
SELL
$57.56 - $82.54 $46,220 - $66,279
-803 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$72.5 - $100.68 $58,217 - $80,846
803 New
803 $62,000
Q3 2021

Oct 15, 2021
SELL
$90.24 - $124.05 $81,125 - $111,520
-899 Closed
0 $0
Q2 2021

Jul 21, 2021
BUY
$93.66 - $139.27 $27,629 - $41,084
295 Added 48.84%
899 $112,000
Q1 2021

Apr 05, 2021
SELL
$116.57 - $155.01 $48,376 - $64,329
-415 Reduced 40.73%
604 $80,000
Q4 2020

Jan 20, 2021
SELL
$99.61 - $142.12 $20,918 - $29,845
-210 Reduced 17.09%
1,019 $135,000
Q3 2020

Oct 19, 2020
BUY
$72.92 - $102.01 $89,618 - $125,370
1,229 New
1,229 $125,000
Q4 2018

Feb 13, 2019
SELL
$56.04 - $82.66 $233,742 - $344,774
-4,171 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$48.29 - $80.6 $201,417 - $336,182
4,171 New
4,171 $329,000
Q1 2018

May 14, 2018
SELL
$39.82 - $57.53 $104,527 - $151,016
-2,625 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $771,036 - $1 Million
-16,585 Reduced 86.34%
2,625 $138,000
Q3 2017

Nov 08, 2017
BUY
$37.05 - $47.12 $711,730 - $905,175
19,210
19,210 $905,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email